These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3940679)

  • 21. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
    Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study.
    Wallace RB; Pomrehn P; Heiss G; Chambless LE; Johnson N; Patten R; Lippel K; Rifkind BM
    Circulation; 1986 Jan; 73(1 Pt 2):I62-9. PubMed ID: 3940685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipoproteinemia in black participants. The Lipid Research Clinics Program Prevalence Study.
    Wilcosky TC; Kwiterovich PO; Glueck CJ; Suchindran CM; Laskarzewski P; Christensen B; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I119-25. PubMed ID: 3940678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A screening survey of dyslipoproteinemias associated with prescription drug use. The Lipid Research Clinics Program Prevalence Study.
    Wallace RB; Hunninghake DB; Chambless LE; Heiss G; Wahl P; Barrett-Connor E
    Circulation; 1986 Jan; 73(1 Pt 2):I70-9. PubMed ID: 2866852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
    Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
    Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary.
    Heiss G; Johnson NJ; Reiland S; Davis CE; Tyroler HA
    Circulation; 1980 Nov; 62(4 Pt 2):IV116-36. PubMed ID: 7418140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profile of women with premature ovarian failure.
    Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
    Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Collaborative Lipid Research Clinics Program Family Study. I. Study design and description of data.
    Am J Epidemiol; 1984 Jun; 119(6):931-43. PubMed ID: 6731432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood lipid characteristics and the incidence of dyslipoproteinemia in the unorganized rural population of Moldova].
    Kishlaru LL
    Lik Sprava; 1995; (3-4):58-61. PubMed ID: 8819923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different types of blood lipoproteins in psoriasis patients. 1. The relationship of dyslipoproteinemias due to disordered cholesterol transport and the course of psoriasis].
    Keshileva ZB; Kosukhin AB; Polevaia LG; Nusupova ZhA
    Vestn Dermatol Venerol; 1990; (2):7-11. PubMed ID: 2343674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
    Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
    Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education.
    Lupien PJ; Moorjani S; Rochon J; Dagenais GR; Fleury LA; Jobin J; Robitaille NM
    CMAJ; 1985 Dec; 133(11):1127-33. PubMed ID: 4063921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of dyslipoproteinemia in a sample of men living in urban and rural areas].
    Mustafina OE; Tuktarova IA; Nafikova VL; Rafikov KhS
    Med Tr Prom Ekol; 1995; (8):10-3. PubMed ID: 8520892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Oklahoma Lipid Research Clinic: research in cardiovascular disease through the Lipid Research Clinics Program.
    Brockway MF; Bradford RH; Anderson PS; Hill J; Mackenthun A
    J Okla State Med Assoc; 1979 Sep; 72(9):323-6. PubMed ID: 501463
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee.
    Circulation; 1979 Aug; 60(2):427-39. PubMed ID: 312704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.